Important Safety Information
Effective Date:
January 1st, 2026
Society provides access to prescription treatments through licensed medical providers. While these treatments can be effective, they are not appropriate for everyone and may carry risks.

Please review the information below carefully before starting any treatment.
1. Medical Consultation Required
All treatments offered through Society require review and approval by a licensed healthcare provider.
  • Not all patients will qualify for treatment
  • Providers may deny, modify, or discontinue treatment at their discretion
  • Treatment decisions are based on your medical history, intake responses, and clinical judgment
2. Prescription Medications
Some treatments available through Society involve prescription medications.

These medications:
  • May cause side effects
  • May interact with other medications or conditions
  • Should only be used as prescribed by a licensed provider
Do not use any prescribed treatment outside of the directions provided.
3. Potential Side Effects
Side effects vary depending on the treatment, but may include:
  • Nausea, headaches, or dizziness
  • Fatigue or changes in appetite
  • Gastrointestinal discomfort
  • Injection-site reactions (for injectable treatments)
More serious side effects are possible. If you experience severe or unexpected symptoms, seek medical attention immediately.
4. Not for Emergency Use
Society does not provide emergency medical services.

If you are experiencing a medical emergency, call 911 or seek immediate care.
5. Individual Results May Vary
Treatment outcomes are not guaranteed.
  • Results differ based on individual health factors
  • Consistency and adherence to treatment matter
  • Some patients may not experience desired outcomes
6. Ongoing Monitoring
Certain treatments require ongoing monitoring and follow-up.
  • Providers may adjust or discontinue treatment based on your progress
  • Failure to follow provider guidance may increase risks
7. Accuracy of Information
You are responsible for providing accurate and complete medical information.

Providing incorrect or incomplete information may:
  • Affect your eligibility for treatment
  • Increase the risk of adverse effects
8. No Guarantee of Prescription
Submitting an intake form or consultation does not guarantee that a prescription will be issued.

All prescriptions are issued solely at the discretion of the licensed provider.
9. Use Only as Directed
Do not:
  • Share your medication with others
  • Use medication for unapproved purposes
  • Modify dosage without provider approval
Misuse may result in serious health risks.
10. Contact a Provider
If you have questions, concerns, or experience side effects, contact your provider or reach out to:
email: support@societyofyou.com
phone: +1 (888) 863-8349 (toll-free)
Treatments
Weight Loss
Performance
Youth
Lab Tests
Company
Home
Patient Portal
Contact
Legal
Privacy Policy
Terms & Conditions
Health Data Policy
Telehealth Consent
Safety Information
* Individual results may vary, and not all patients will qualify for treatment. Always consult a licensed healthcare provider before starting or modifying any medical treatment.

Society facilitates access to consultations with independent, licensed healthcare providers who evaluate each patient and determine eligibility for treatment. Prescription products require an online medical evaluation. Medications are prescribed by independent physicians and dispensed by licensed U.S. pharmacies or a patient’s preferred pharmacy. Only a qualified healthcare provider can determine whether a treatment is appropriate for an individual’s specific medical needs.

Society partners with licensed U.S. pharmacies. Certain treatments may include compounded medications, which are not FDA-approved and have not been evaluated by the Food and Drug Administration for safety, efficacy, or quality. Compounded medications may be prescribed by a healthcare provider based on individual patient needs or during periods of drug shortages. FDA-approved GLP-1 medications—such as Ozempic® (semaglutide), Wegovy® (semaglutide), and Zepbound® (tirzepatide)—are not compounded. Society is not affiliated with, endorsed by, or sponsored by the manufacturers of these products. All trademarks and brand names belong to their respective owners.

GLP-1–based treatments may carry risks, including the potential for thyroid C-cell tumors. These medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Please consult a healthcare provider for complete prescribing and safety information.

Statements on this website have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Product packaging and appearance may vary.